Ethical issues in neuro-oncology

被引:2
作者
Newton, HB
Malkin, MG
机构
[1] OHIO STATE UNIV HOSP,DEPT NEUROSCI,COLUMBUS,OH 43210
[2] MEM SLOAN KETTERING CANC CTR,DEPT NEUROL,NEW YORK,NY 10021
关键词
ethics; neuro-oncology; brain tumors; quality of life; hospice;
D O I
10.1055/s-2008-1040932
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Ethical issues and dilemmas are common in patients with brain tumors and other neuro-oncologic diseases. Basic knowledge of ethical principles and theory is essential for the day-to-day care of these patients, which often involves life and death decisions. The most important ethical principles include respect for autonomy, justice, beneficience, and nonmaleficence. The application of these principles is important for resolving ethical questions related to neuro-oncology patients such as discussing diagnosis and prognosis, whether or not to initiate therapy (including clinical trials), quality of life during and after treatment, when it is appropriate to stop treatment, if hospice care should be implemented, and pain control. Frequent consideration of these basic ethical principles will assist physicians during the decision-making process and improve their ability to make sound choices.
引用
收藏
页码:219 / 226
页数:8
相关论文
共 49 条
[1]  
ALLEN JC, 1985, CANCER, V56, P1827, DOI 10.1002/1097-0142(19851001)56:7+<1827::AID-CNCR2820561322>3.0.CO
[2]  
2-5
[3]   LEPTOMENINGEAL METASTASIS FROM SUPRATENTORIAL MALIGNANT GLIOMAS [J].
AWAD, I ;
BAY, JW ;
ROGERS, L .
NEUROSURGERY, 1986, 19 (02) :247-251
[4]   The neurologist and the dying patient [J].
Bernat, JL ;
Goldstein, ML ;
Viste, MK .
NEUROLOGY, 1996, 46 (03) :598-599
[5]   BRAIN-TUMORS .2. [J].
BLACK, PM .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (22) :1555-1564
[6]   ETHICS AND CANCER-THERAPY [J].
BLUMBERG, BS .
BIOMEDICINE & PHARMACOTHERAPY, 1993, 47 (09) :393-395
[7]  
Butow PN, 1996, CANCER-AM CANCER SOC, V77, P2630, DOI 10.1002/(SICI)1097-0142(19960615)77:12<2630::AID-CNCR29>3.3.CO
[8]  
2-K
[9]  
Cella D F, 1995, Oncology (Williston Park), V9, P47
[10]  
CHERNY NI, 1993, CANCER-AM CANCER SOC, V72, P3393, DOI 10.1002/1097-0142(19931201)72:11+<3393::AID-CNCR2820721606>3.0.CO